Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection. Shengir M, Fillebeen C, Wagner J, Ramanakumar AV, et al. J Acquir Immune Defic Syndr 2023 Jun 27. doi: 10.1097/QAI.0000000000003245.

Read + Share

Amedeo Smart

Independent Medical Education

Shengir M, Fillebeen C, Wagner J, Ramanakumar AV, et al. Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection. J Acquir Immune Defic Syndr 2023 Jun 27. doi: 10.1097/QAI.0000000000003245.
PMID: 37368933